AR128071A1 - Composiciones liposomales de oxazolidinona - Google Patents

Composiciones liposomales de oxazolidinona

Info

Publication number
AR128071A1
AR128071A1 ARP220103554A ARP220103554A AR128071A1 AR 128071 A1 AR128071 A1 AR 128071A1 AR P220103554 A ARP220103554 A AR P220103554A AR P220103554 A ARP220103554 A AR P220103554A AR 128071 A1 AR128071 A1 AR 128071A1
Authority
AR
Argentina
Prior art keywords
liposomes
compound
lipid
cholesterol
extruded
Prior art date
Application number
ARP220103554A
Other languages
English (en)
Spanish (es)
Inventor
Dmitri B Kirpotin
Alexander Koshkaryev
Charles O Noble
Daryl C Drummond
Original Assignee
Akagera Medicines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akagera Medicines Inc filed Critical Akagera Medicines Inc
Publication of AR128071A1 publication Critical patent/AR128071A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP220103554A 2021-12-22 2022-12-22 Composiciones liposomales de oxazolidinona AR128071A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163292899P 2021-12-22 2021-12-22

Publications (1)

Publication Number Publication Date
AR128071A1 true AR128071A1 (es) 2024-03-20

Family

ID=86903807

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220103554A AR128071A1 (es) 2021-12-22 2022-12-22 Composiciones liposomales de oxazolidinona

Country Status (12)

Country Link
US (2) US20250064739A1 (cg-RX-API-DMAC7.html)
EP (1) EP4452252A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025501769A (cg-RX-API-DMAC7.html)
KR (1) KR20240152302A (cg-RX-API-DMAC7.html)
CN (1) CN118900689A (cg-RX-API-DMAC7.html)
AR (1) AR128071A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022420614A1 (cg-RX-API-DMAC7.html)
CA (1) CA3241952A1 (cg-RX-API-DMAC7.html)
IL (1) IL313709A (cg-RX-API-DMAC7.html)
MX (1) MX2024007588A (cg-RX-API-DMAC7.html)
WO (1) WO2023122759A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA202404799B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102859152B1 (ko) * 2024-10-24 2025-09-12 주식회사 한국리포좀 합성 지질 리포좀 기반의 일본 뇌염 바이러스 백신 및 그의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180134B1 (en) * 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
TWI378092B (en) * 2003-06-03 2012-12-01 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
US8658203B2 (en) * 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
WO2007005754A2 (en) * 2005-07-01 2007-01-11 Alza Corporation Liposomal delivery vehicle for hydrophobic drugs
US20180344644A1 (en) * 2015-09-21 2018-12-06 Mallinckrodt Llc Improved stability of liposome formulations and uses thereof
AU2021292747A1 (en) * 2020-06-18 2023-02-23 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof

Also Published As

Publication number Publication date
AU2022420614A1 (en) 2024-06-27
US20260083674A1 (en) 2026-03-26
EP4452252A2 (en) 2024-10-30
EP4452252A4 (en) 2025-12-03
KR20240152302A (ko) 2024-10-21
WO2023122759A3 (en) 2023-08-31
MX2024007588A (es) 2024-07-09
IL313709A (en) 2024-08-01
US20250064739A1 (en) 2025-02-27
JP2025501769A (ja) 2025-01-23
WO2023122759A2 (en) 2023-06-29
CN118900689A (zh) 2024-11-05
CA3241952A1 (en) 2023-06-29
ZA202404799B (en) 2025-12-17

Similar Documents

Publication Publication Date Title
AU763989B2 (en) Quinolone containing liposomes and their use as antibacterial agents
US11517553B2 (en) Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
WO2016086136A1 (en) Fatty acid cysteamine conjugates of cftr modulators and their use in treating medical disorders
CN102223878A (zh) 包含鞘磷脂的脂质体系统
AR075447A1 (es) Sales y polimorfos de un compuesto de tetraciclina, metodo de obtencion y composiciones farmaceuticas
RU2014122432A (ru) Способ получения липидных наночастиц для доставки лекарственного средства
JP2002511099A (ja) 親油性化合物用の自己乳化性処方
AU2013292636A1 (en) Liposomal compositions of epoxyketone-based proteasome inhibitors
JP2016529284A5 (cg-RX-API-DMAC7.html)
RU2016143590A (ru) Липосомальные композиции ципрофлоксацина, обладающие активностью против нетуберкулезных микробактерий
AR082049A1 (es) Formulaciones liquidas de rupatadina fumarato
PT1551370E (pt) Agregado com capacidade de deformação aumentada, que compreende pelo menos três anfipáticos, para o transporte melhorado através de barreiras semi-permeáveis e para a aplicação de fármaco não invasiva in vivo, especialmente através da pele
JP5588619B2 (ja) pH応答性リポソーム
JP2023531666A5 (cg-RX-API-DMAC7.html)
IL299155B1 (en) Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
ES2303114T3 (es) Metodo para cargar medicamentos en liposomas.
JP6230538B2 (ja) 安定なオキサリプラチン封入リポソーム水分散液及びその安定化方法
AR085273A1 (es) Formulacion liquida libre de propelente que comprende una droga antimuscarinica
CA2041075A1 (en) Process for the production of aqueous liposome suspensions containing active ingredients
SI2847204T1 (en) Sterol derivatives and their use for the treatment of diseases involving the transformation of astrocytic cells or the treatment of malignant haemopathies
KR20110083604A (ko) 피라졸론 유도체 제제
US20250134811A1 (en) Ultraflexible liposomes in gel formulation
AR038764A1 (es) Formulacion de una solucion de inhalacion con una sal de tiotropio
JP2025501769A5 (cg-RX-API-DMAC7.html)
KR20140017516A (ko) 피리디늄 및 퀴놀리늄 유도체의 약학 조성물